Schizophrenia is a severe brain disorder thought to be caused by a complex interplay of genetic predisposition and environmental exposure.
1-5 In the context of gene-environment interplay and developmental programming,
6,7 epigenetic mechanisms, such as DNA methylation, have received substantial attention in schizophrenia
8,9 and other neuropsychiatric disorders.
10-13 As epigenetic mechanisms may account for heritability not captured by other current methods, such as polygenic risk scores (PRSs), potential interactions between genetic susceptibility and epigenetic changes are of particular interest. To our knowledge, to date, much of this work has studied single genes. For example, methylation at the single-nucleotide polymorphism rs6265 within the neurodevelopmentally important brain-derived neurotrophic factor gene shows a genotype-dependent association with working memory (WM), hypoxia-associated early life events, and a WM-associated schizophrenia intermediate phenotype.
14 Similarly, methylation differences in dopamine receptor D4 predict WM, suggesting that the dopaminergic methylation status could affect cognitive functions in a dissociable manner.
15 Likewise, membrane-bound catechol-O-methyltransferase promoter methylation is associated with dorsolateral prefrontal cortex (DLPFC) activity during WM
16 and methylation of the
COMT Val(158) allele with lifetime stress, WM performance, and prefrontal activity during WM.
17